Web-based Smoking Cessation Program for Tribal College Students

Sponsor
Won Choi, PhD, MPH (Other)
Overall Status
Completed
CT.gov ID
NCT02050308
Collaborator
National Cancer Institute (NCI) (NIH)
251
2
2
47
125.5
2.7

Study Details

Study Description

Brief Summary

The purpose of this study is to test the effectiveness of a culturally-tailored Internet-based program that helps American Indian (AI) tribal college students quit smoking.

Condition or Disease Intervention/Treatment Phase
  • Other: Internet-All Nations Breath of Life (I-ANBL)
  • Other: Honoring the Gift of Heart Health
  • Drug: Nicotine gum, Patch, or Lozenge or Zyban® or Chantix®
Phase 3

Detailed Description

Many of the approximately 25,000 American Indian (AI) students enrolled in tribal colleges/universities in the US arrive there as smokers. A 2011 study of high school seniors reported that the smoking prevalence among AI students is approximately 40%, the highest rate among all racial and ethnic groups studied. Although prevalence data on smoking among AI college students are limited, studies have shown that the majority of smokers in high school continue to smoke once they reach college. Prohibited from marketing to adolescents and children, the tobacco industry in recent years has shifted its most intense marketing to college students, resulting in increases in smoking rates among them. The transition to college provides amble opportunities for young adults to acquire new and harmful habits. Many of these habits do not seem so alien to young AIs: Cigarette smoking is the number one cause of preventable death among AIs. Cancer is the second leading cause of death among AIs, and lung cancer is the leading cause of cancer deaths for both AI men and women. Cultural factors, socioeconomic circumstances, and lack of culturally-tailored cessation programs for American Indian tribal college students have prevented access to effective interventions that promote smoking cessation. To date, few studies have focused on methods to encourage smoking cessation among tribal college students and no randomized clinical trials have yet been conducted. To address this public health deficit, we propose an innovative, effective, culturally and individually-tailored smoking cessation programs to promote cessation.

Primary aim is to: To test the effectiveness of a culturally-tailored internet-based smoking cessation intervention (I-ANBL) compared to an internet-based heart healthy diet (I-FV:fruit/vegetable) control condition in a randomized controlled trial with Tribal College students. Our hypothesis is that American Indian tribal college students randomized to the culturally-tailored smoking cessation arm will have significantly higher 7-day point prevalence abstinence (defined as no cigarettes in the past 7 days, biochemically verified) rates at 6 months than those receiving the heart healthy diet intervention.

Study Design

Study Type:
Interventional
Actual Enrollment :
251 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
None (Open Label)
Primary Purpose:
Prevention
Official Title:
Web-based Smoking Cessation Program for Tribal College Students
Study Start Date :
May 1, 2015
Actual Primary Completion Date :
Mar 31, 2019
Actual Study Completion Date :
Mar 31, 2019

Arms and Interventions

Arm Intervention/Treatment
Experimental: Internet-All Nations Breath of Life (I-ANBL)

The culturally-tailored program includes 9 individual Internet-based sessions across a 12 week period and an additional individual Internet-based session at 6 months. Web sessions will last about half-an-hour (30 minutes) and will discuss topics that are important to quitting smoking (like: preparing to quit, dealing with cravings, and support systems, etc.) and topics relevant to American Indian culture (like traditional use of tobacco). We plan to give participants in our cessation program a choice of varenicline, bupropion, nicotine replacement therapy or no pharmacotherapy. We choose to give our participants a choice because our experience shows that we would be unlikely to recruit AI participants into a trial that requires pharmacotherapy use.

Other: Internet-All Nations Breath of Life (I-ANBL)
Participants will be asked to log into the website prior to the first session to allow for any problems with the site to be fixed prior to sessions starting. Topics we anticipate covering include, but are not limited to: preparing to quit, dealing with cravings, support systems, traditional tobacco, stress reduction, weight management, and staying quit, along with other topics determined during program development. For each session, the tribal college student will begin the session by answering a series of questions to produce an individually-tailored report that will be provided on the screen at the end of each week's session so that the smoker can work on strategies during the week before the next internet session Weekly procedures will follow the same format as for the first session

Drug: Nicotine gum, Patch, or Lozenge or Zyban® or Chantix®
Regardless of the intervention arm to which subjects are assigned, they will choose the option of nicotine replacement therapy they want, as long as they are eligible for it. All participants are offered the medications, but they do not have to take any medication to participate in the study.
Other Names:
  • Nictotine Replacement Therapy (Nicotine gum, Patch, or Lozenge) or Pharmacotherapy (Zyban® or Chantix®)
  • Active Comparator: Honoring the Gift of Heart Health

    The culturally-tailored program includes 9 individual Internet-based sessions across a 12 week period and an additional individual Internet-based session at 6 months. Web sessions will last about half-an-hour (30 minutes) and will discuss topics that are important to heart health (like: Assessing risk for heart disease, increasing fruit and vegetable consumption, physical activity, etc.). We plan to give participants in our cessation program a choice of varenicline, bupropion, nicotine replacement therapy or no pharmacotherapy. We choose to give our participants a choice because our experience shows that we would be unlikely to recruit AI participants into a trial that requires pharmacotherapy use.

    Other: Honoring the Gift of Heart Health
    These sessions help American Indians learn about what they can do to prevent heart disease. We will emphasize the increase consumption of fruits and vegetables as well as addressing other heart healthy activities. Honoring the Gift of Heart Health is a user-friendly program developed especially for American Indians. The manual provides the "how-to" for leading group education sessions. It offers "hands-on" activities that help people build the skills they need to make simple, practical, and lasting changes to help them fight heart disease. The protocol will follow procedures as the I-ANBL arm, however, this fruit and vegetable arm will not include individually tailored components, but just interactive web-based materials related to increasing heart health, including certain activities.

    Drug: Nicotine gum, Patch, or Lozenge or Zyban® or Chantix®
    Regardless of the intervention arm to which subjects are assigned, they will choose the option of nicotine replacement therapy they want, as long as they are eligible for it. All participants are offered the medications, but they do not have to take any medication to participate in the study.
    Other Names:
  • Nictotine Replacement Therapy (Nicotine gum, Patch, or Lozenge) or Pharmacotherapy (Zyban® or Chantix®)
  • Outcome Measures

    Primary Outcome Measures

    1. Number of Participants With 7-day Point Prevalence Abstinence [6 months]

      self-reported and biochemically (salivary cotinine) verified point prevalence abstinence, defined as no smoking for the previous 7 days, at the 6-month follow-up.

    Secondary Outcome Measures

    1. Cigarettes Per Day [Change from Baseline in number of cigarettes smoked daily at 6 months]

      effect of intervention on the number of cigarettes smoked daily among those who continue to smoke at Month 6

    2. Number of Quit Attempts [6 months]

      comparison of the number of serious quit attempts between the two groups using Poisson regression

    3. Number of Participants Who Participated in All Sessions Over the Course of 6 Months. [6 months]

      Number of participants who participated in all online sessions and study protocol procedures over the course of 6 months

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    18 Years and Older
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    Yes
    Inclusion Criteria:
    • Currently enrolled at Salish Kootenai College

    • Have a valid telephone number and email address

    • Willing to participate in all study components

    • Willing to be followed-up for 6 months

    • Self identifies as American Indian or Alaska Native

    • Is a current smoker

    Exclusion Criteria:
    • Planning to leave college within next 6 months

    • Medically ineligible as a result of screening questions

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 University of Kansas Medical Center Kansas City Kansas United States 66160
    2 Salish Kootenai College Pablo Montana United States 59855

    Sponsors and Collaborators

    • Won Choi, PhD, MPH
    • National Cancer Institute (NCI)

    Investigators

    • Principal Investigator: Won Choi, PhD, MPH, University of Kansas Medical Center

    Study Documents (Full-Text)

    More Information

    Publications

    None provided.
    Responsible Party:
    Won Choi, PhD, MPH, Professor, University of Kansas Medical Center
    ClinicalTrials.gov Identifier:
    NCT02050308
    Other Study ID Numbers:
    • 13613
    • R01CA174481
    First Posted:
    Jan 30, 2014
    Last Update Posted:
    Dec 7, 2021
    Last Verified:
    Nov 1, 2021
    Additional relevant MeSH terms:

    Study Results

    Participant Flow

    Recruitment Details
    Pre-assignment Detail
    Arm/Group Title Honoring the Gift of Heart Health Internet-All Nations Breath of Life (I-ANBL)
    Arm/Group Description The culturally-tailored program includes 9 individual Internet-based sessions across a 12 week period and an additional individual Internet-based session at 6 months. Web sessions will last about half-an-hour (30 minutes) and will discuss topics that are important to heart health (like: Assessing risk for heart disease, increasing fruit and vegetable consumption, physical activity, etc.). Participants in our cessation program have a choice of varenicline, bupropion, nicotine replacement therapy or no pharmacotherapy. The culturally-tailored program includes 9 individual Internet-based sessions across a 12 week period and an additional individual Internet-based session at 6 months. Web sessions will last about half-an-hour (30 minutes) and will discuss topics that are important to quitting smoking (like: preparing to quit, dealing with cravings, and support systems, etc.) and topics relevant to American Indian culture (like traditional use of tobacco). Participants in our cessation program have a choice of varenicline, bupropion, nicotine replacement therapy or no pharmacotherapy.
    Period Title: Overall Study
    STARTED 127 124
    COMPLETED 28 22
    NOT COMPLETED 99 102

    Baseline Characteristics

    Arm/Group Title Honoring the Gift of Heart Health Internet-All Nations Breath of Life (I-ANBL) Total
    Arm/Group Description The culturally-tailored program includes 9 individual Internet-based sessions across a 12 week period and an additional individual Internet-based session at 6 months. Web sessions will last about half-an-hour (30 minutes) and will discuss topics that are important to heart health (like: Assessing risk for heart disease, increasing fruit and vegetable consumption, physical activity, etc.). Participants in our cessation program have a choice of varenicline, bupropion, nicotine replacement therapy or no pharmacotherapy. The culturally-tailored program includes 9 individual Internet-based sessions across a 12 week period and an additional individual Internet-based session at 6 months. Web sessions will last about half-an-hour (30 minutes) and will discuss topics that are important to quitting smoking (like: preparing to quit, dealing with cravings, and support systems, etc.) and topics relevant to American Indian culture (like traditional use of tobacco). Participants in our cessation program have a choice of varenicline, bupropion, nicotine replacement therapy or no pharmacotherapy. Total of all reporting groups
    Overall Participants 127 124 251
    Age (Count of Participants)
    <=18 years
    0
    0%
    0
    0%
    0
    0%
    Between 18 and 65 years
    127
    100%
    124
    100%
    251
    100%
    >=65 years
    0
    0%
    0
    0%
    0
    0%
    Sex: Female, Male (Count of Participants)
    Female
    67
    52.8%
    61
    49.2%
    128
    51%
    Male
    59
    46.5%
    63
    50.8%
    122
    48.6%
    Race (NIH/OMB) (Count of Participants)
    American Indian or Alaska Native
    127
    100%
    124
    100%
    251
    100%
    Asian
    0
    0%
    0
    0%
    0
    0%
    Native Hawaiian or Other Pacific Islander
    0
    0%
    0
    0%
    0
    0%
    Black or African American
    0
    0%
    0
    0%
    0
    0%
    White
    0
    0%
    0
    0%
    0
    0%
    More than one race
    0
    0%
    0
    0%
    0
    0%
    Unknown or Not Reported
    0
    0%
    0
    0%
    0
    0%
    Region of Enrollment (participants) [Number]
    United States
    127
    100%
    124
    100%
    251
    100%

    Outcome Measures

    1. Primary Outcome
    Title Number of Participants With 7-day Point Prevalence Abstinence
    Description self-reported and biochemically (salivary cotinine) verified point prevalence abstinence, defined as no smoking for the previous 7 days, at the 6-month follow-up.
    Time Frame 6 months

    Outcome Measure Data

    Analysis Population Description
    [Not Specified]
    Arm/Group Title Honoring the Gift of Heart Health Internet-All Nations Breath of Life (I-ANBL)
    Arm/Group Description The culturally-tailored program includes 9 individual Internet-based sessions across a 12 week period and an additional individual Internet-based session at 6 months. Web sessions will last about half-an-hour (30 minutes) and will discuss topics that are important to heart health (like: Assessing risk for heart disease, increasing fruit and vegetable consumption, physical activity, etc.). Participants in our cessation program have a choice of varenicline, bupropion, nicotine replacement therapy or no pharmacotherapy. The culturally-tailored program includes 9 individual Internet-based sessions across a 12 week period and an additional individual Internet-based session at 6 months. Web sessions will last about half-an-hour (30 minutes) and will discuss topics that are important to quitting smoking (like: preparing to quit, dealing with cravings, and support systems, etc.) and topics relevant to American Indian culture (like traditional use of tobacco). Participants in our cessation program have a choice of varenicline, bupropion, nicotine replacement therapy or no pharmacotherapy.
    Measure Participants 127 124
    Count of Participants [Participants]
    9
    7.1%
    9
    7.3%
    2. Secondary Outcome
    Title Cigarettes Per Day
    Description effect of intervention on the number of cigarettes smoked daily among those who continue to smoke at Month 6
    Time Frame Change from Baseline in number of cigarettes smoked daily at 6 months

    Outcome Measure Data

    Analysis Population Description
    Smokers who were randomized to the Internet All Nations Breath of Life intervention or the Heart Healthy arm focusing on increasing fruits and vegetables. Due to very low retention rate at 6 months (less than 20%), no data were collected at 6 months. Therefore, the data below are baseline mean number of cigarettes smoked by intervention arm.
    Arm/Group Title Internet All Nations Breath of Life Honoring the Gift of Heart Health
    Arm/Group Description Internet based All Nations Breath of Life Smoking Cessation program Internet based heart healthy program to increase fruits and vegetables
    Measure Participants 124 127
    Mean (Standard Deviation) [Cigarettes/day]
    4.00
    (5.15)
    5.43
    (5.42)
    3. Secondary Outcome
    Title Number of Quit Attempts
    Description comparison of the number of serious quit attempts between the two groups using Poisson regression
    Time Frame 6 months

    Outcome Measure Data

    Analysis Population Description
    Overall retention at 6 months was low at 20% so no data were collected at 6 months.
    Arm/Group Title I-ANBL Honoring the Gift of Heart Health
    Arm/Group Description Internet All Nations Breath of Life Increasing fruit and vegetable consumption
    Measure Participants 0 0
    4. Secondary Outcome
    Title Number of Participants Who Participated in All Sessions Over the Course of 6 Months.
    Description Number of participants who participated in all online sessions and study protocol procedures over the course of 6 months
    Time Frame 6 months

    Outcome Measure Data

    Analysis Population Description
    The overall retention rate at 6 months was low at 20% so no data were collected at 6 months.
    Arm/Group Title Internet All Nations Breath of Life Honoring the Gift of Heart Health
    Arm/Group Description Internet Based All Nations Breath of Life Smoking Cessation Program Increasing fruit and vegetable consumption
    Measure Participants 0 0

    Adverse Events

    Time Frame 6 months
    Adverse Event Reporting Description
    Arm/Group Title Honoring the Gift of Heart Health Internet-All Nations Breath of Life (I-ANBL)
    Arm/Group Description The culturally-tailored program includes 9 individual Internet-based sessions across a 12 week period and an additional individual Internet-based session at 6 months. Web sessions will last about half-an-hour (30 minutes) and will discuss topics that are important to heart health (like: Assessing risk for heart disease, increasing fruit and vegetable consumption, physical activity, etc.). Participants in our cessation program have a choice of varenicline, bupropion, nicotine replacement therapy or no pharmacotherapy. The culturally-tailored program includes 9 individual Internet-based sessions across a 12 week period and an additional individual Internet-based session at 6 months. Web sessions will last about half-an-hour (30 minutes) and will discuss topics that are important to quitting smoking (like: preparing to quit, dealing with cravings, and support systems, etc.) and topics relevant to American Indian culture (like traditional use of tobacco). Participants in our cessation program have a choice of varenicline, bupropion, nicotine replacement therapy or no pharmacotherapy.
    All Cause Mortality
    Honoring the Gift of Heart Health Internet-All Nations Breath of Life (I-ANBL)
    Affected / at Risk (%) # Events Affected / at Risk (%) # Events
    Total 0/127 (0%) 0/124 (0%)
    Serious Adverse Events
    Honoring the Gift of Heart Health Internet-All Nations Breath of Life (I-ANBL)
    Affected / at Risk (%) # Events Affected / at Risk (%) # Events
    Total 0/127 (0%) 0/124 (0%)
    Other (Not Including Serious) Adverse Events
    Honoring the Gift of Heart Health Internet-All Nations Breath of Life (I-ANBL)
    Affected / at Risk (%) # Events Affected / at Risk (%) # Events
    Total 0/127 (0%) 0/124 (0%)

    Limitations/Caveats

    Significant loss to follow-up, lower than expected salivary collection rates, and lower long-term retention of participants.

    More Information

    Certain Agreements

    Principal Investigators are NOT employed by the organization sponsoring the study.

    There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.

    Results Point of Contact

    Name/Title Dr. Won S. Choi
    Organization The University of Kansas Medical Center
    Phone (913) 588-4742
    Email wchoi@kumc.edu
    Responsible Party:
    Won Choi, PhD, MPH, Professor, University of Kansas Medical Center
    ClinicalTrials.gov Identifier:
    NCT02050308
    Other Study ID Numbers:
    • 13613
    • R01CA174481
    First Posted:
    Jan 30, 2014
    Last Update Posted:
    Dec 7, 2021
    Last Verified:
    Nov 1, 2021